Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients.
Alexis Guerin-DubourgMaxime CournotCynthia PlanesseXavier DebusscheOlivier MeilhacPhilippe RondeauEmmanuel BourdonPublished in: BioMed research international (2017)
These results bring new evidence for the potential interest of glycated albumin, oxidative stress, and glycoxidation parameters in the monitoring of type 2 diabetic patients. Furthermore, it emphasizes fluorescent AGEs as a putative indicator for vascular event prediction in diabetic patients.